New HIF-2 kidney cancer therapy more effective than current treatment, study shows

Monday, September 5, 2016 - 14:31 in Health & Medicine

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers have found.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net